摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1'R,5α,6R,7R,14α)-1'-phenyl-1‘-(4,5-epoxy-7,8-dihydro-3-hydroxy-6-methoxy-7β-methyl-17-cyclopropylmethyl-6,14-ethenomorphinan-7-yl)methan-1’-ol | 1417783-82-4

中文名称
——
中文别名
——
英文名称
(1'R,5α,6R,7R,14α)-1'-phenyl-1‘-(4,5-epoxy-7,8-dihydro-3-hydroxy-6-methoxy-7β-methyl-17-cyclopropylmethyl-6,14-ethenomorphinan-7-yl)methan-1’-ol
英文别名
BU128;(1R,2S,6R,14R,15R,19R)-5-(cyclopropylmethyl)-19-[(R)-hydroxy(phenyl)methyl]-15-methoxy-19-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-ol
(1'R,5α,6R,7R,14α)-1'-phenyl-1‘-(4,5-epoxy-7,8-dihydro-3-hydroxy-6-methoxy-7β-methyl-17-cyclopropylmethyl-6,14-ethenomorphinan-7-yl)methan-1’-ol化学式
CAS
1417783-82-4
化学式
C31H35NO4
mdl
——
分子量
485.623
InChiKey
NZCUONOJSJVNOY-KTLUODIZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    36
  • 可旋转键数:
    5
  • 环数:
    9.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    62.2
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    N-cyclopropylmethyl-6,14-endo-etheno-7β-methylnorisonepenthol 在 六甲基磷酰三胺1-丙烷硫醇钠氯化铵盐酸 作用下, 以 乙醇 为溶剂, 反应 3.0h, 以103 mg的产率得到(1'R,5α,6R,7R,14α)-1'-phenyl-1‘-(4,5-epoxy-7,8-dihydro-3-hydroxy-6-methoxy-7β-methyl-17-cyclopropylmethyl-6,14-ethenomorphinan-7-yl)methan-1’-ol
    参考文献:
    名称:
    ORVINOL AND THEVINOL DERIVATIVES USEFUL IN THE TREATMENT OF DRUG AND ALCOHOL ABUSE
    摘要:
    这项发明提供了用于治疗药物和酒精滥用的奥维诺尔(orvinol)和西维诺尔(thevinol)化合物,这些化合物特别适用于预防康复成瘾者的复发。
    公开号:
    US20140213603A1
点击查看最新优质反应信息

文献信息

  • Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse, depression, anxiety, or a compulsive disorder
    申请人:The University of Bath
    公开号:US10030031B2
    公开(公告)日:2018-07-24
    The invention provides a method of treating drug and alcohol abuse, depression, anxiety, or a compulsive disorder in a subject comprising administering to the subject a compound having the formula: or a pharmaceutically acceptable salt or solvate thereof, wherein R, R1, R2, R3, R4, R5, and X are as defined in the specification.
    本发明提供了一种治疗吸毒和酗酒、抑郁、焦虑或强迫症的方法,该方法包括向受试者施用一种具有以下式子的化合物: 或其药学上可接受的盐或溶液,其中 R、R1、R2、R3、R4、R5 和 X 如说明书中所定义。
  • Orvinol and Thevinol Derivatives Useful in the Treatment of Drug and Alcohol Abuse
    申请人:The University of Bath
    公开号:US20150202200A1
    公开(公告)日:2015-07-23
    The invention provides orvinol and thevinol compounds useful for the treatment of drug and alcohol abuse, the compounds being particularly useful for the prevention of relapse in recovering addicts.
  • Orvinol and Thevinol Derivatives Useful in the Treatment of Anxiety or a Compulsive Disorder
    申请人:The University of Bath
    公开号:US20160136151A1
    公开(公告)日:2016-05-19
    The invention provides a method of treating anxiety or a compulsive disorder in a subject comprising administering to the subject a compound having formula 2: or a pharmaceutically acceptable salt or solvate thereof, wherein R, R 1 , R 2 , R 3 , R 4 , R 5 , and X are as defined in the specification.
  • Orvinol and Thevinol Derivatives Useful in the Treatment of Drug and Alcohol Abuse, Depression, Anxiety, or a Compulsive Disorder
    申请人:The University of Bath
    公开号:US20170044173A1
    公开(公告)日:2017-02-16
    The invention provides a method of treating drug and alcohol abuse, depression, anxiety, or a compulsive disorder in a subject comprising administering to the subject a compound having formula 2 : or a pharmaceutically acceptable salt or solvate thereof, wherein R, R 1 , R 2 , R 3 , R 4 , R 5 , and X are as defined in the specification.
  • US9051334B2
    申请人:——
    公开号:US9051334B2
    公开(公告)日:2015-06-09
查看更多